Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 28, 2014; 20(36): 13044-13051
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.13044
Capsule endoscopy in Crohn’s disease: Are we seeing any better?
David Hudesman, Jonathan Mazurek, Arun Swaminath
David Hudesman, Inflammatory Bowel Disease Center, Division of Digestive Diseases, Mount Sinai Beth Israel, New York, NY 10003, United States
Jonathan Mazurek, Division of Digestive Diseases, Mount Sinai Beth Israel, New York, NY 10003, United States
Arun Swaminath, Division of Gastroenterology, NSLIJ Lenox Hill Hospital, New York, NY 10075, United States
Author contributions: Swaminath A contributed to concept and design; Hudesman D, Mazurek J and Swaminath A analyzed and interpreted data, drafted the manuscript and revised the manuscript for important intellectual content.
Correspondence to: Arun Swaminath, MD, Division of Gastroenterology, NSLIJ Lenox Hill Hospital, 100 East 77th Street, 2nd Floor, New York, NY 10075, United States. aswaminath@nshs.edu
Telephone: +1-212-4346785 Fax: +1-212-4346275
Received: March 1, 2014
Revised: June 3, 2014
Accepted: June 14, 2014
Published online: September 28, 2014
Processing time: 214 Days and 16.9 Hours
Core Tip

Core tip: Crohn’s disease (CD) is a complex, immune-mediated disorder that often requires a multi-modality approach for optimal diagnosis and management. Over the past decade, capsule endoscopy (CE) has increasingly found a place in the algorithm for the diagnosis, treatment and monitoring of CD. CE potentially offers a noninvasive approach to evaluate areas of the small bowel that may be difficult to access with traditional endoscopy. Furthermore, CE has potential application for specific subsegments of patients with inflammatory bowel disease (IBD), such as those with IBD unclassified, pediatric patients and patients with CD who have previously undergone surgery.